Fulcrum Therapeutics Inc (FULC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.01 -0.08 (-2.59%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.00 -0.01 (-0.33%) 18:06 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,725 | 6,843 | 28,539 | -26,870 | -97,335 |
| Depreciation Amortization | 1,593 | 1,224 | 855 | 479 | 2,172 |
| Accounts receivable | -1,559 | -3,119 | -1,796 | 537 | -308 |
| Accounts payable and accrued liabilities | -1,593 | 1,104 | 807 | 1,100 | -853 |
| Other Working Capital | -4,248 | -2,154 | -1,744 | -1,648 | -4,613 |
| Other Operating Activity | 13,314 | 10,645 | 6,954 | 1,118 | 9,972 |
| Operating Cash Flow | $-2,218 | $14,543 | $33,615 | $-25,284 | $-90,965 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,508 | 30,017 | 25,648 | 38,156 | -36,184 |
| PPE Investments | -278 | -47 | -28 | -28 | -508 |
| Investing Cash Flow | $32,230 | $29,970 | $25,620 | $38,128 | $-36,692 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,746 | 2,663 | 2,028 | 1,651 | 118,122 |
| Financing Cash Flow | $2,746 | $2,663 | $2,028 | $1,651 | $118,122 |
| Beginning Cash Position | 26,655 | 26,655 | 26,655 | 26,655 | 36,190 |
| End Cash Position | 59,413 | 73,831 | 87,918 | 41,150 | 26,655 |
| Net Cash Flow | $32,758 | $47,176 | $61,263 | $14,495 | $-9,535 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,218 | 14,543 | 33,615 | -25,284 | -90,965 |
| Capital Expenditure | -278 | -47 | -28 | -28 | -508 |
| Free Cash Flow | -2,496 | 14,496 | 33,587 | -25,312 | -91,473 |